NCT03830359 is a NA clinical trial of T2769 in Dry Eye Syndrome, sponsored by Laboratoires Thea.

Who is sponsoring NCT03830359?

NCT03830359 is sponsored by Laboratoires Thea.

What drugs are being tested in NCT03830359?

Interventions in NCT03830359: T2769.

What condition does NCT03830359 study?

NCT03830359 studies Dry Eye Syndrome.

Is NCT03830359 still recruiting?

NCT03830359 is currently completed. Last updated 16 March 2022.

Are results published for NCT03830359?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-03-16 · How we verify

NCT03830359

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy, Safety of T2769 in Dry Eye Disease

Completed NA Results posted Last updated 16 March 2022

What this trial tests

NA trial testing T2769 in Dry Eye Syndrome in 62 participants. Completed in 18 February 2019.

Timeline

1 September 2018

Primary endpoint
18 February 2019

18 February 2019

Quick facts

Lead sponsor	Laboratoires Thea
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	62
Start date	1 September 2018
Primary completion	18 February 2019
Estimated completion	18 February 2019
Sites	3 locations across Tunisia

Drugs / interventions tested

T2769

Conditions studied

Dry Eye Syndrome — all drugs for Dry Eye Syndrome →

Sponsor

Laboratoires Thea — full company profile →

Who can join

18 and older, any sex, with Dry Eye Syndrome. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Ocular Symptomatology Primary · Baseline and Day 42

Change from baseline in ocular symptomatology on a Visual Analog Scale (0=No discomfort and 100=Maximal discomfort) at Day 42.

Group	Value	95% CI
T2769	-55.9	± 23.1

Sponsor's own description

Efficacy of T2769 in Dry Eye Desease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of T2769

Trials testing the same drug.

NCT07007702 — Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Dise · completed
NCT06375499 — Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. · NA · completed
NCT05965778 — Performance and Safety of T2769 in DED · NA · completed
NCT05931861 — Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms. · NA · completed

Other recruiting trials for Dry Eye Syndrome

Currently open trials in the same condition.

NCT07295691 — Autologous Serum Eye Drops in Dry Eye Syndrome · NA · recruiting
NCT06914232 — Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES · NA · active not recruiting
NCT06913556 — Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP · NA · active not recruiting

Other Laboratoires Thea trials

Trials by the same sponsor.

NCT07169695 — A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern · Phase 2 · recruiting
NCT07234318 — A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyc · active not recruiting
NCT07234292 — Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery. · not yet recruiting
NCT07007702 — Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Dise · completed
NCT06375499 — Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03830359 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laboratoires Thea
Last refreshed: 16 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing